BRIEF published on 10/22/2024 at 18:55, 29 days 15 hours ago Verallia Reports Q3 2024 Results Amid Market Challenges Market Challenges Revenue Decline Decarbonization Efforts Q3 2024 Results Debt And Acquisition
PRESS RELEASE published on 10/22/2024 at 18:50, 29 days 15 hours ago Inside Information / News release on accounts, results Verallia returns to moderate organic volume growth in 2024 Q3 despite challenging market, with adjusted EBITDA expected to be on par with 2022. Inaugurates 100% electric furnace in Cognac for sector's decarbonization Decarbonization Adjusted EBITDA Verallia Organic Volume Growth Electric Furnace
BRIEF published on 07/23/2024 at 10:57, 3 months 28 days ago Threshold crossing for VERALLIA Voting Rights Amundi Asset Management Crossing Threshold FCPE Verallia Fusion-absorption
BRIEF published on 07/16/2024 at 19:05, 4 months 4 days ago Half-year review of Verallia's liquidity contract Securities Euronext Paris Liquidity Contract Transactions Verallia
PRESS RELEASE published on 07/16/2024 at 19:00, 4 months 4 days ago Inside Information / Other news releases Verallia releases 2024 half-yearly report on liquidity agreement with Rothschild Martin Maurel. Details include shares, euros, purchases, sales, and volumes Euronext Paris Shares Liquidity Agreement Half-yearly Report Verallia
BRIEF published on 07/08/2024 at 19:05, 4 months 12 days ago Verallia Revises 2024 EBITDA Forecast Amid Slower Recovery EBITDA Forecast Cost Reduction 2024 Financial Results Demand Recovery Verallia
PRESS RELEASE published on 07/08/2024 at 19:00, 4 months 12 days ago Inside Information / Other news releases Verallia reports slower than anticipated recovery in activity for 2024, revises adjusted EBITDA expectation to be around the same level as in 2022 Adjusted EBITDA 2024 Recovery Activity Verallia
BRIEF published on 06/28/2024 at 11:19, 4 months 22 days ago Crossing of threshold by Amundi Asset Management at Verallia Voting Rights Amundi Transfer Of Shares Crossing Threshold Verallia
Published on 11/21/2024 at 10:03, 43 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 46 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 46 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 11 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 21 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 15 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 41 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 43 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 45 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 46 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 48 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 26 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 1 minute ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 1 minute ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
